(19)
(11) EP 3 585 813 A1

(12)

(43) Date of publication:
01.01.2020 Bulletin 2020/01

(21) Application number: 18713075.2

(22) Date of filing: 22.02.2018
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
(86) International application number:
PCT/US2018/019248
(87) International publication number:
WO 2018/156777 (30.08.2018 Gazette 2018/35)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD TN

(30) Priority: 22.02.2017 US 201762462272 P

(71) Applicant: Sutro Biopharma, Inc.
South San Francisco, California 94080 (US)

(72) Inventors:
  • STAFFORD, Ryan
    South San Francisco California 94080 (US)
  • YAM, Alice
    South San Francisco California 94080 (US)
  • ARMSTRONG, Stephanie
    South San Francisco California 94080 (US)
  • LEE, John
    South San Francisco California 94080 (US)
  • STEINER, Alexander
    South San Francisco California 94080 (US)
  • YANG, Junhao
    South San Francisco California 94080 (US)
  • CHENG, Christine
    South San Francisco California 94080 (US)

(74) Representative: Hutter, Anton et al
Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park
Guildford GU2 7RF
Guildford GU2 7RF (GB)

   


(54) PD-1/TIM-3 BI-SPECIFIC ANTIBODIES, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME